Novo Nordisk's Q2 2025 sales surge as Wegovy demand grows, driven by new obesity drug data. Click here to read an analysis of ...

Ozempic, marketed by Novo Nordisk in India, is primarily indicated for the treatment of type 2 diabetes. While it can lead to ...

Firm Novo Nordisk’s global patent is set to expire in parts of the world from early 2026, allowing cut-price ‘own-label’ ...

Discover how Trump’s 100% drug tariff impacts NVO, SNY, and AZN stocks. Click for which pharma giants face the most risk—and ...

U.S. President Donald Trump on Thursday unveiled a 100% tariff on imports of branded drugs from October 1, unless their ...

While Trump’s move threatens to double the cost of some imported treatments if construction on US manufacturing sites hasn’t ...

Now, it’s worth noting Stock Advisor’s total average return is 1,058% — a market-crushing outperformance compared to 189 % for the S&P 500. Don’t miss out on the latest top 10 list, available when you ...

Friday, September 26, 2025 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including NVIDIA ...

BLOCKBUSTER weight loss jabs could soon be sold for as little as £20 a month. Firms may be able to make their own “generic” versions of the drugs for much cheaper from early next year, ...

SEPT 26 - Bosch is set to cut 13,000 jobs as part of its plans to save €2.5bn (£2.06bn). The engineering giant said the losses, in its mobility division Kenya breaking news | Kenya news today | ...